nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0198	0.0286	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0198	0.0286	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0171	0.0247	CbGbCtD
Caffeine—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0171	0.0247	CbGbCtD
Caffeine—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0166	0.024	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0166	0.024	CbGbCtD
Caffeine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0165	0.0238	CbGbCtD
Caffeine—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.015	0.0217	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.015	0.0217	CbGbCtD
Caffeine—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.015	0.0217	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.015	0.0217	CbGbCtD
Caffeine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0149	0.0215	CbGbCtD
Caffeine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0149	0.0215	CbGbCtD
Caffeine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0145	0.021	CbGbCtD
Caffeine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0143	0.0207	CbGbCtD
Caffeine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0143	0.0207	CbGbCtD
Caffeine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.013	0.0188	CbGbCtD
Caffeine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0128	0.0185	CbGbCtD
Caffeine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0125	0.018	CbGbCtD
Caffeine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0123	0.0177	CbGbCtD
Caffeine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0123	0.0177	CbGbCtD
Caffeine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0117	0.0169	CbGbCtD
Caffeine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0113	0.0163	CbGbCtD
Caffeine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0113	0.0163	CbGbCtD
Caffeine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0111	0.016	CbGbCtD
Caffeine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.011	0.0159	CbGbCtD
Caffeine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.011	0.0159	CbGbCtD
Caffeine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0108	0.0157	CbGbCtD
Caffeine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0108	0.0157	CbGbCtD
Caffeine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0107	0.0155	CbGbCtD
Caffeine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0107	0.0155	CbGbCtD
Caffeine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0104	0.015	CbGbCtD
Caffeine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0101	0.0146	CbGbCtD
Caffeine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0101	0.0146	CbGbCtD
Caffeine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00998	0.0144	CbGbCtD
Caffeine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00998	0.0144	CbGbCtD
Caffeine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00969	0.014	CbGbCtD
Caffeine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00928	0.0134	CbGbCtD
Caffeine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00913	0.0132	CbGbCtD
Caffeine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00913	0.0132	CbGbCtD
Caffeine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00862	0.0124	CbGbCtD
Caffeine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0084	0.0121	CbGbCtD
Caffeine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00837	0.0121	CbGbCtD
Caffeine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00836	0.0121	CbGbCtD
Caffeine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00812	0.0117	CbGbCtD
Caffeine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00788	0.0114	CbGbCtD
Caffeine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00765	0.011	CbGbCtD
Caffeine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00757	0.0109	CbGbCtD
Caffeine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00757	0.0109	CbGbCtD
Caffeine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00734	0.0106	CbGbCtD
Caffeine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00734	0.0106	CbGbCtD
Caffeine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00725	0.0105	CbGbCtD
Caffeine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00704	0.0102	CbGbCtD
Caffeine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00692	0.00998	CbGbCtD
Caffeine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00692	0.00998	CbGbCtD
Caffeine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00683	0.00985	CbGbCtD
Caffeine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00642	0.00926	CbGbCtD
Caffeine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00642	0.00926	CbGbCtD
Caffeine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0058	0.00838	CbGbCtD
Caffeine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0058	0.00838	CbGbCtD
Caffeine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00545	0.00786	CbGbCtD
Caffeine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00501	0.00723	CbGbCtD
Caffeine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00486	0.00702	CbGbCtD
Caffeine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0044	0.00635	CbGbCtD
Caffeine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0044	0.00635	CbGbCtD
Caffeine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00422	0.00609	CbGbCtD
Caffeine—Regurgitation—Indinavir—acquired immunodeficiency syndrome	0.00398	0.035	CcSEcCtD
Caffeine—PIK3CD—nerve—acquired immunodeficiency syndrome	0.00348	0.0332	CbGeAlD
Caffeine—PIK3CB—nerve—acquired immunodeficiency syndrome	0.00303	0.029	CbGeAlD
Caffeine—PIK3CA—nerve—acquired immunodeficiency syndrome	0.003	0.0287	CbGeAlD
Caffeine—PIK3CD—endothelium—acquired immunodeficiency syndrome	0.00296	0.0283	CbGeAlD
Caffeine—PIK3CD—blood plasma—acquired immunodeficiency syndrome	0.00263	0.0251	CbGeAlD
Caffeine—PIK3CB—endothelium—acquired immunodeficiency syndrome	0.00258	0.0247	CbGeAlD
Caffeine—PIK3CA—endothelium—acquired immunodeficiency syndrome	0.00256	0.0244	CbGeAlD
Caffeine—PIK3CB—blood plasma—acquired immunodeficiency syndrome	0.00229	0.0219	CbGeAlD
Caffeine—PIK3CA—blood plasma—acquired immunodeficiency syndrome	0.00227	0.0217	CbGeAlD
Caffeine—Acidosis—Zidovudine—acquired immunodeficiency syndrome	0.00189	0.0166	CcSEcCtD
Caffeine—Haemoglobin decreased—Nelfinavir—acquired immunodeficiency syndrome	0.00175	0.0154	CcSEcCtD
Caffeine—Haemoglobin decreased—Stavudine—acquired immunodeficiency syndrome	0.00175	0.0153	CcSEcCtD
Caffeine—ADORA1—nerve—acquired immunodeficiency syndrome	0.00159	0.0152	CbGeAlD
Caffeine—PRKDC—retina—acquired immunodeficiency syndrome	0.00154	0.0147	CbGeAlD
Caffeine—PIK3CD—retina—acquired immunodeficiency syndrome	0.00144	0.0138	CbGeAlD
Caffeine—ATM—skin of body—acquired immunodeficiency syndrome	0.00143	0.0136	CbGeAlD
Caffeine—Cerebral haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.0124	CcSEcCtD
Caffeine—Haemoglobin decreased—Indinavir—acquired immunodeficiency syndrome	0.00141	0.0124	CcSEcCtD
Caffeine—Accidental injury—Nelfinavir—acquired immunodeficiency syndrome	0.00136	0.012	CcSEcCtD
Caffeine—Accidental injury—Stavudine—acquired immunodeficiency syndrome	0.00136	0.0119	CcSEcCtD
Caffeine—Acidosis—Lamivudine—acquired immunodeficiency syndrome	0.00135	0.0118	CcSEcCtD
Caffeine—PIK3CD—skin of body—acquired immunodeficiency syndrome	0.00126	0.0121	CbGeAlD
Caffeine—PIK3CB—retina—acquired immunodeficiency syndrome	0.00126	0.012	CbGeAlD
Caffeine—Creatinine increased—Abacavir—acquired immunodeficiency syndrome	0.00125	0.0109	CcSEcCtD
Caffeine—PIK3CA—retina—acquired immunodeficiency syndrome	0.00124	0.0119	CbGeAlD
Caffeine—ATM—lymphoid tissue—acquired immunodeficiency syndrome	0.00115	0.011	CbGeAlD
Caffeine—ATM—digestive system—acquired immunodeficiency syndrome	0.00114	0.0109	CbGeAlD
Caffeine—Haemoglobin decreased—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00998	CcSEcCtD
Caffeine—Hypercalcaemia—Saquinavir—acquired immunodeficiency syndrome	0.00113	0.00989	CcSEcCtD
Caffeine—PIK3CB—skin of body—acquired immunodeficiency syndrome	0.0011	0.0105	CbGeAlD
Caffeine—PIK3CA—skin of body—acquired immunodeficiency syndrome	0.00109	0.0104	CbGeAlD
Caffeine—ATM—blood—acquired immunodeficiency syndrome	0.00109	0.0104	CbGeAlD
Caffeine—ATM—bone marrow—acquired immunodeficiency syndrome	0.00105	0.01	CbGeAlD
Caffeine—Hypoglycaemia—Didanosine—acquired immunodeficiency syndrome	0.00103	0.00905	CcSEcCtD
Caffeine—PRKDC—blood—acquired immunodeficiency syndrome	0.00103	0.00981	CbGeAlD
Caffeine—PIK3CD—lymphoid tissue—acquired immunodeficiency syndrome	0.00102	0.00978	CbGeAlD
Caffeine—Creatinine increased—Indinavir—acquired immunodeficiency syndrome	0.00102	0.00897	CcSEcCtD
Caffeine—PIK3CD—digestive system—acquired immunodeficiency syndrome	0.00101	0.00966	CbGeAlD
Caffeine—ATM—vagina—acquired immunodeficiency syndrome	0.00101	0.00962	CbGeAlD
Caffeine—PRKDC—bone marrow—acquired immunodeficiency syndrome	0.000994	0.00949	CbGeAlD
Caffeine—PRKDC—spinal cord—acquired immunodeficiency syndrome	0.000989	0.00945	CbGeAlD
Caffeine—Creatinine increased—Efavirenz—acquired immunodeficiency syndrome	0.000965	0.00847	CcSEcCtD
Caffeine—PIK3CD—blood—acquired immunodeficiency syndrome	0.000963	0.0092	CbGeAlD
Caffeine—Injury—Nelfinavir—acquired immunodeficiency syndrome	0.000953	0.00837	CcSEcCtD
Caffeine—ATM—lung—acquired immunodeficiency syndrome	0.000952	0.0091	CbGeAlD
Caffeine—PRKDC—vagina—acquired immunodeficiency syndrome	0.000952	0.0091	CbGeAlD
Caffeine—Injury—Stavudine—acquired immunodeficiency syndrome	0.00095	0.00834	CcSEcCtD
Caffeine—Urine output increased—Zidovudine—acquired immunodeficiency syndrome	0.000945	0.0083	CcSEcCtD
Caffeine—PIK3CD—bone marrow—acquired immunodeficiency syndrome	0.000932	0.0089	CbGeAlD
Caffeine—PIK3CD—spinal cord—acquired immunodeficiency syndrome	0.000928	0.00887	CbGeAlD
Caffeine—Accidental injury—Ritonavir—acquired immunodeficiency syndrome	0.000919	0.00807	CcSEcCtD
Caffeine—PRKDC—lung—acquired immunodeficiency syndrome	0.0009	0.0086	CbGeAlD
Caffeine—Hypoglycaemia—Nelfinavir—acquired immunodeficiency syndrome	0.000898	0.00788	CcSEcCtD
Caffeine—PIK3CB—lymphoid tissue—acquired immunodeficiency syndrome	0.000893	0.00853	CbGeAlD
Caffeine—PIK3CA—lymphoid tissue—acquired immunodeficiency syndrome	0.000883	0.00844	CbGeAlD
Caffeine—PIK3CB—digestive system—acquired immunodeficiency syndrome	0.000882	0.00843	CbGeAlD
Caffeine—ATM—nervous system—acquired immunodeficiency syndrome	0.000882	0.00842	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.000876	0.00769	CcSEcCtD
Caffeine—PIK3CA—digestive system—acquired immunodeficiency syndrome	0.000873	0.00834	CbGeAlD
Caffeine—Hyperglycaemia—Amprenavir—acquired immunodeficiency syndrome	0.00086	0.00755	CcSEcCtD
Caffeine—ATM—central nervous system—acquired immunodeficiency syndrome	0.000849	0.00811	CbGeAlD
Caffeine—Deafness—Zidovudine—acquired immunodeficiency syndrome	0.000849	0.00745	CcSEcCtD
Caffeine—PIK3CD—lung—acquired immunodeficiency syndrome	0.000844	0.00807	CbGeAlD
Caffeine—PIK3CB—blood—acquired immunodeficiency syndrome	0.00084	0.00803	CbGeAlD
Caffeine—RYR1—blood—acquired immunodeficiency syndrome	0.000831	0.00794	CbGeAlD
Caffeine—PIK3CA—blood—acquired immunodeficiency syndrome	0.000831	0.00794	CbGeAlD
Caffeine—Urine output increased—Efavirenz—acquired immunodeficiency syndrome	0.000831	0.00729	CcSEcCtD
Caffeine—Creatinine increased—Saquinavir—acquired immunodeficiency syndrome	0.000822	0.00722	CcSEcCtD
Caffeine—PIK3CB—bone marrow—acquired immunodeficiency syndrome	0.000813	0.00777	CbGeAlD
Caffeine—PIK3CB—spinal cord—acquired immunodeficiency syndrome	0.000809	0.00773	CbGeAlD
Caffeine—Blood creatinine increased—Abacavir—acquired immunodeficiency syndrome	0.000806	0.00707	CcSEcCtD
Caffeine—PIK3CA—bone marrow—acquired immunodeficiency syndrome	0.000804	0.00769	CbGeAlD
Caffeine—PIK3CA—spinal cord—acquired immunodeficiency syndrome	0.000801	0.00765	CbGeAlD
Caffeine—Dry skin—Stavudine—acquired immunodeficiency syndrome	0.000801	0.00703	CcSEcCtD
Caffeine—Urine output increased—Delavirdine—acquired immunodeficiency syndrome	0.000795	0.00698	CcSEcCtD
Caffeine—Hyperglycaemia—Didanosine—acquired immunodeficiency syndrome	0.000784	0.00688	CcSEcCtD
Caffeine—PIK3CD—nervous system—acquired immunodeficiency syndrome	0.000782	0.00747	CbGeAlD
Caffeine—PIK3CB—vagina—acquired immunodeficiency syndrome	0.000779	0.00744	CbGeAlD
Caffeine—RYR1—vagina—acquired immunodeficiency syndrome	0.000771	0.00736	CbGeAlD
Caffeine—PIK3CA—vagina—acquired immunodeficiency syndrome	0.000771	0.00736	CbGeAlD
Caffeine—Gastritis—Abacavir—acquired immunodeficiency syndrome	0.000761	0.00668	CcSEcCtD
Caffeine—PIK3CD—central nervous system—acquired immunodeficiency syndrome	0.000753	0.00719	CbGeAlD
Caffeine—PIK3CB—lung—acquired immunodeficiency syndrome	0.000736	0.00704	CbGeAlD
Caffeine—Urine output increased—Ritonavir—acquired immunodeficiency syndrome	0.000735	0.00645	CcSEcCtD
Caffeine—PIK3CA—lung—acquired immunodeficiency syndrome	0.000729	0.00696	CbGeAlD
Caffeine—Irritability—Zidovudine—acquired immunodeficiency syndrome	0.000725	0.00636	CcSEcCtD
Caffeine—Cardiac disorder—Amprenavir—acquired immunodeficiency syndrome	0.000709	0.00622	CcSEcCtD
Caffeine—Hyperglycaemia—Nevirapine—acquired immunodeficiency syndrome	0.000705	0.00619	CcSEcCtD
Caffeine—Injury—Delavirdine—acquired immunodeficiency syndrome	0.000694	0.00609	CcSEcCtD
Caffeine—Renal failure—Nevirapine—acquired immunodeficiency syndrome	0.000685	0.00601	CcSEcCtD
Caffeine—Hyperglycaemia—Nelfinavir—acquired immunodeficiency syndrome	0.000683	0.006	CcSEcCtD
Caffeine—PIK3CB—nervous system—acquired immunodeficiency syndrome	0.000682	0.00652	CbGeAlD
Caffeine—Hyperglycaemia—Stavudine—acquired immunodeficiency syndrome	0.000681	0.00598	CcSEcCtD
Caffeine—Urine output increased—Lamivudine—acquired immunodeficiency syndrome	0.000675	0.00592	CcSEcCtD
Caffeine—RYR1—nervous system—acquired immunodeficiency syndrome	0.000675	0.00645	CbGeAlD
Caffeine—PIK3CA—nervous system—acquired immunodeficiency syndrome	0.000675	0.00645	CbGeAlD
Caffeine—ATM—brain—acquired immunodeficiency syndrome	0.000674	0.00644	CbGeAlD
Caffeine—Hyperglycaemia—Abacavir—acquired immunodeficiency syndrome	0.000671	0.00589	CcSEcCtD
Caffeine—Malnutrition—Amprenavir—acquired immunodeficiency syndrome	0.000665	0.00583	CcSEcCtD
Caffeine—Blood creatinine increased—Indinavir—acquired immunodeficiency syndrome	0.000661	0.00581	CcSEcCtD
Caffeine—Deafness—Ritonavir—acquired immunodeficiency syndrome	0.00066	0.00579	CcSEcCtD
Caffeine—PIK3CB—central nervous system—acquired immunodeficiency syndrome	0.000657	0.00627	CbGeAlD
Caffeine—Renal failure—Abacavir—acquired immunodeficiency syndrome	0.000652	0.00572	CcSEcCtD
Caffeine—ATM—lymph node—acquired immunodeficiency syndrome	0.000651	0.00622	CbGeAlD
Caffeine—RYR1—central nervous system—acquired immunodeficiency syndrome	0.00065	0.00621	CbGeAlD
Caffeine—PIK3CA—central nervous system—acquired immunodeficiency syndrome	0.00065	0.00621	CbGeAlD
Caffeine—Sepsis—Lamivudine—acquired immunodeficiency syndrome	0.000648	0.00569	CcSEcCtD
Caffeine—Dry skin—Indinavir—acquired immunodeficiency syndrome	0.000647	0.00568	CcSEcCtD
Caffeine—Injury—Ritonavir—acquired immunodeficiency syndrome	0.000642	0.00564	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Delavirdine—acquired immunodeficiency syndrome	0.000638	0.0056	CcSEcCtD
Caffeine—PRKDC—brain—acquired immunodeficiency syndrome	0.000637	0.00609	CbGeAlD
Caffeine—Deafness—Saquinavir—acquired immunodeficiency syndrome	0.000635	0.00557	CcSEcCtD
Caffeine—Blood creatinine increased—Efavirenz—acquired immunodeficiency syndrome	0.000625	0.00548	CcSEcCtD
Caffeine—Gastritis—Indinavir—acquired immunodeficiency syndrome	0.000625	0.00548	CcSEcCtD
Caffeine—Injury—Saquinavir—acquired immunodeficiency syndrome	0.000618	0.00542	CcSEcCtD
Caffeine—PRKDC—lymph node—acquired immunodeficiency syndrome	0.000616	0.00588	CbGeAlD
Caffeine—ADORA2B—blood—acquired immunodeficiency syndrome	0.000612	0.00584	CbGeAlD
Caffeine—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.000609	0.00535	CcSEcCtD
Caffeine—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.000606	0.00532	CcSEcCtD
Caffeine—Deafness—Lamivudine—acquired immunodeficiency syndrome	0.000606	0.00532	CcSEcCtD
Caffeine—Blood creatinine increased—Delavirdine—acquired immunodeficiency syndrome	0.000598	0.00525	CcSEcCtD
Caffeine—PIK3CD—brain—acquired immunodeficiency syndrome	0.000598	0.00571	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00059	0.00518	CcSEcCtD
Caffeine—Injury—Lamivudine—acquired immunodeficiency syndrome	0.00059	0.00517	CcSEcCtD
Caffeine—Dry skin—Delavirdine—acquired immunodeficiency syndrome	0.000585	0.00513	CcSEcCtD
Caffeine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000582	0.00556	CbGeAlD
Caffeine—Hypoglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.000582	0.00511	CcSEcCtD
Caffeine—PIK3CD—lymph node—acquired immunodeficiency syndrome	0.000577	0.00552	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000568	0.00499	CcSEcCtD
Caffeine—ADORA2B—vagina—acquired immunodeficiency syndrome	0.000567	0.00542	CbGeAlD
Caffeine—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000565	0.00496	CcSEcCtD
Caffeine—Gastritis—Delavirdine—acquired immunodeficiency syndrome	0.000565	0.00496	CcSEcCtD
Caffeine—Hypoglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000555	0.00487	CcSEcCtD
Caffeine—Hyperglycaemia—Indinavir—acquired immunodeficiency syndrome	0.00055	0.00483	CcSEcCtD
Caffeine—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000547	0.0048	CcSEcCtD
Caffeine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000545	0.00521	CbGeAlD
Caffeine—Irritability—Saquinavir—acquired immunodeficiency syndrome	0.000542	0.00476	CcSEcCtD
Caffeine—Dry skin—Ritonavir—acquired immunodeficiency syndrome	0.000541	0.00475	CcSEcCtD
Caffeine—ADORA2A—lymphoid tissue—acquired immunodeficiency syndrome	0.000541	0.00517	CbGeAlD
Caffeine—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.000538	0.00472	CcSEcCtD
Caffeine—ADORA2B—lung—acquired immunodeficiency syndrome	0.000536	0.00512	CbGeAlD
Caffeine—Renal failure—Indinavir—acquired immunodeficiency syndrome	0.000535	0.00469	CcSEcCtD
Caffeine—Blood creatinine increased—Saquinavir—acquired immunodeficiency syndrome	0.000532	0.00467	CcSEcCtD
Caffeine—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.000532	0.00467	CcSEcCtD
Caffeine—Malnutrition—Nelfinavir—acquired immunodeficiency syndrome	0.000528	0.00463	CcSEcCtD
Caffeine—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.000527	0.00462	CcSEcCtD
Caffeine—Malnutrition—Stavudine—acquired immunodeficiency syndrome	0.000526	0.00462	CcSEcCtD
Caffeine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000526	0.00502	CbGeAlD
Caffeine—Gastritis—Ritonavir—acquired immunodeficiency syndrome	0.000522	0.00458	CcSEcCtD
Caffeine—PIK3CB—brain—acquired immunodeficiency syndrome	0.000521	0.00498	CbGeAlD
Caffeine—Dry skin—Saquinavir—acquired immunodeficiency syndrome	0.000521	0.00457	CcSEcCtD
Caffeine—Hyperglycaemia—Efavirenz—acquired immunodeficiency syndrome	0.00052	0.00456	CcSEcCtD
Caffeine—Malnutrition—Abacavir—acquired immunodeficiency syndrome	0.000518	0.00455	CcSEcCtD
Caffeine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000517	0.00494	CbGeAlD
Caffeine—RYR1—brain—acquired immunodeficiency syndrome	0.000516	0.00493	CbGeAlD
Caffeine—PIK3CA—brain—acquired immunodeficiency syndrome	0.000516	0.00493	CbGeAlD
Caffeine—Infestation—Efavirenz—acquired immunodeficiency syndrome	0.000514	0.00451	CcSEcCtD
Caffeine—Infestation NOS—Efavirenz—acquired immunodeficiency syndrome	0.000514	0.00451	CcSEcCtD
Caffeine—ADORA2A—blood—acquired immunodeficiency syndrome	0.000509	0.00486	CbGeAlD
Caffeine—Renal failure—Efavirenz—acquired immunodeficiency syndrome	0.000505	0.00444	CcSEcCtD
Caffeine—PIK3CB—lymph node—acquired immunodeficiency syndrome	0.000504	0.00481	CbGeAlD
Caffeine—Gastritis—Saquinavir—acquired immunodeficiency syndrome	0.000503	0.00441	CcSEcCtD
Caffeine—PIK3CA—lymph node—acquired immunodeficiency syndrome	0.000498	0.00476	CbGeAlD
Caffeine—Hyperglycaemia—Delavirdine—acquired immunodeficiency syndrome	0.000498	0.00437	CcSEcCtD
Caffeine—ADORA2B—nervous system—acquired immunodeficiency syndrome	0.000497	0.00474	CbGeAlD
Caffeine—Infection—Didanosine—acquired immunodeficiency syndrome	0.000491	0.00431	CcSEcCtD
Caffeine—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.000491	0.00431	CcSEcCtD
Caffeine—ADORA2A—spinal cord—acquired immunodeficiency syndrome	0.00049	0.00469	CbGeAlD
Caffeine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00049	0.00468	CbGeAlD
Caffeine—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.000488	0.00429	CcSEcCtD
Caffeine—Cardiac disorder—Zidovudine—acquired immunodeficiency syndrome	0.000487	0.00428	CcSEcCtD
Caffeine—Agitation—Nelfinavir—acquired immunodeficiency syndrome	0.000485	0.00426	CcSEcCtD
Caffeine—ADORA2B—central nervous system—acquired immunodeficiency syndrome	0.000478	0.00457	CbGeAlD
Caffeine—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000468	0.00411	CcSEcCtD
Caffeine—Hyperglycaemia—Ritonavir—acquired immunodeficiency syndrome	0.00046	0.00404	CcSEcCtD
Caffeine—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.000457	0.00401	CcSEcCtD
Caffeine—Convulsion—Nelfinavir—acquired immunodeficiency syndrome	0.000457	0.00401	CcSEcCtD
Caffeine—Convulsion—Abacavir—acquired immunodeficiency syndrome	0.000449	0.00394	CcSEcCtD
Caffeine—Renal failure—Ritonavir—acquired immunodeficiency syndrome	0.000447	0.00392	CcSEcCtD
Caffeine—Nervousness—Zidovudine—acquired immunodeficiency syndrome	0.000444	0.0039	CcSEcCtD
Caffeine—Hyperglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.000443	0.00389	CcSEcCtD
Caffeine—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000441	0.00387	CcSEcCtD
Caffeine—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.000438	0.00384	CcSEcCtD
Caffeine—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.000438	0.00384	CcSEcCtD
Caffeine—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000436	0.00383	CcSEcCtD
Caffeine—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000432	0.00379	CcSEcCtD
Caffeine—Renal failure—Saquinavir—acquired immunodeficiency syndrome	0.00043	0.00378	CcSEcCtD
Caffeine—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.000428	0.00376	CcSEcCtD
Caffeine—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.000425	0.00373	CcSEcCtD
Caffeine—ADORA1—spinal cord—acquired immunodeficiency syndrome	0.000423	0.00405	CbGeAlD
Caffeine—Hyperglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000422	0.00371	CcSEcCtD
Caffeine—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000421	0.00369	CcSEcCtD
Caffeine—Infection—Abacavir—acquired immunodeficiency syndrome	0.00042	0.00369	CcSEcCtD
Caffeine—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000418	0.00367	CcSEcCtD
Caffeine—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000417	0.00366	CcSEcCtD
Caffeine—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000417	0.00366	CcSEcCtD
Caffeine—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000415	0.00364	CcSEcCtD
Caffeine—ADORA2A—nervous system—acquired immunodeficiency syndrome	0.000413	0.00395	CbGeAlD
Caffeine—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.000413	0.00362	CcSEcCtD
Caffeine—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000411	0.00361	CcSEcCtD
Caffeine—Renal failure—Lamivudine—acquired immunodeficiency syndrome	0.000411	0.0036	CcSEcCtD
Caffeine—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.00041	0.0036	CcSEcCtD
Caffeine—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000408	0.00358	CcSEcCtD
Caffeine—ADORA1—vagina—acquired immunodeficiency syndrome	0.000407	0.00389	CbGeAlD
Caffeine—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000402	0.00353	CcSEcCtD
Caffeine—ADORA2A—central nervous system—acquired immunodeficiency syndrome	0.000398	0.0038	CbGeAlD
Caffeine—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000396	0.00348	CcSEcCtD
Caffeine—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.000395	0.00347	CcSEcCtD
Caffeine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000394	0.00377	CbGeAlD
Caffeine—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000393	0.00345	CcSEcCtD
Caffeine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000391	0.00343	CcSEcCtD
Caffeine—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.00039	0.00342	CcSEcCtD
Caffeine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000388	0.00371	CbGeAlD
Caffeine—ADORA1—lung—acquired immunodeficiency syndrome	0.000385	0.00368	CbGeAlD
Caffeine—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000384	0.00337	CcSEcCtD
Caffeine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000384	0.00337	CcSEcCtD
Caffeine—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000384	0.00337	CcSEcCtD
Caffeine—ADORA2B—brain—acquired immunodeficiency syndrome	0.00038	0.00363	CbGeAlD
Caffeine—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000379	0.00333	CcSEcCtD
Caffeine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000377	0.00331	CcSEcCtD
Caffeine—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000373	0.00328	CcSEcCtD
Caffeine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000372	0.00326	CcSEcCtD
Caffeine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000371	0.00325	CcSEcCtD
Caffeine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000369	0.00324	CcSEcCtD
Caffeine—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.00324	CcSEcCtD
Caffeine—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000366	0.00321	CcSEcCtD
Caffeine—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000366	0.00349	CbGeAlD
Caffeine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000365	0.0032	CcSEcCtD
Caffeine—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000365	0.0032	CcSEcCtD
Caffeine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000364	0.0032	CcSEcCtD
Caffeine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000362	0.00318	CcSEcCtD
Caffeine—ADORA1—nervous system—acquired immunodeficiency syndrome	0.000357	0.00341	CbGeAlD
Caffeine—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000355	0.00312	CcSEcCtD
Caffeine—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000355	0.00312	CcSEcCtD
Caffeine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000353	0.0031	CcSEcCtD
Caffeine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00305	CcSEcCtD
Caffeine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000347	0.00304	CcSEcCtD
Caffeine—PDE4B—lymphoid tissue—acquired immunodeficiency syndrome	0.000345	0.0033	CbGeAlD
Caffeine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.00303	CcSEcCtD
Caffeine—ADORA1—central nervous system—acquired immunodeficiency syndrome	0.000343	0.00328	CbGeAlD
Caffeine—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000342	0.003	CcSEcCtD
Caffeine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000342	0.003	CcSEcCtD
Caffeine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000342	0.003	CcSEcCtD
Caffeine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00034	0.00299	CcSEcCtD
Caffeine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000339	0.00297	CcSEcCtD
Caffeine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000337	0.00296	CcSEcCtD
Caffeine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000333	0.00292	CcSEcCtD
Caffeine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000332	0.00291	CcSEcCtD
Caffeine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000328	0.00288	CcSEcCtD
Caffeine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00287	CcSEcCtD
Caffeine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.00286	CcSEcCtD
Caffeine—PDE4B—blood—acquired immunodeficiency syndrome	0.000325	0.00311	CbGeAlD
Caffeine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000322	0.00283	CcSEcCtD
Caffeine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000322	0.00282	CcSEcCtD
Caffeine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00032	0.00281	CcSEcCtD
Caffeine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.0028	CcSEcCtD
Caffeine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000317	0.00278	CcSEcCtD
Caffeine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000317	0.00278	CcSEcCtD
Caffeine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000316	0.00278	CcSEcCtD
Caffeine—ADORA2A—brain—acquired immunodeficiency syndrome	0.000316	0.00302	CbGeAlD
Caffeine—PDE4B—bone marrow—acquired immunodeficiency syndrome	0.000315	0.00301	CbGeAlD
Caffeine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000314	0.00276	CcSEcCtD
Caffeine—PDE4B—spinal cord—acquired immunodeficiency syndrome	0.000313	0.00299	CbGeAlD
Caffeine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000312	0.00274	CcSEcCtD
Caffeine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.00274	CcSEcCtD
Caffeine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000312	0.00273	CcSEcCtD
Caffeine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000311	0.00273	CcSEcCtD
Caffeine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000309	0.00272	CcSEcCtD
Caffeine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.0027	CcSEcCtD
Caffeine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.00269	CcSEcCtD
Caffeine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.00269	CcSEcCtD
Caffeine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000305	0.00267	CcSEcCtD
Caffeine—PDE4B—vagina—acquired immunodeficiency syndrome	0.000301	0.00288	CbGeAlD
Caffeine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.0003	0.00263	CcSEcCtD
Caffeine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.0026	CcSEcCtD
Caffeine—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000296	0.00283	CbGeAlD
Caffeine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00259	CcSEcCtD
Caffeine—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000292	0.00279	CbGeAlD
Caffeine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.00257	CcSEcCtD
Caffeine—PDE4B—lung—acquired immunodeficiency syndrome	0.000285	0.00272	CbGeAlD
Caffeine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.0025	CcSEcCtD
Caffeine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.00248	CcSEcCtD
Caffeine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.00248	CcSEcCtD
Caffeine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.00248	CcSEcCtD
Caffeine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00247	CcSEcCtD
Caffeine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00028	0.00246	CcSEcCtD
Caffeine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00028	0.00246	CcSEcCtD
Caffeine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.00245	CcSEcCtD
Caffeine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000279	0.00267	CbGeAlD
Caffeine—CYP1B1—blood—acquired immunodeficiency syndrome	0.000279	0.00266	CbGeAlD
Caffeine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.00243	CcSEcCtD
Caffeine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.0024	CcSEcCtD
Caffeine—ADORA1—brain—acquired immunodeficiency syndrome	0.000273	0.00261	CbGeAlD
Caffeine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000271	0.00238	CcSEcCtD
Caffeine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000271	0.00238	CcSEcCtD
Caffeine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00238	CcSEcCtD
Caffeine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.00238	CcSEcCtD
Caffeine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000271	0.00238	CcSEcCtD
Caffeine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00027	0.00237	CcSEcCtD
Caffeine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000267	0.00234	CcSEcCtD
Caffeine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000266	0.00234	CcSEcCtD
Caffeine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00232	CcSEcCtD
Caffeine—PDE4B—nervous system—acquired immunodeficiency syndrome	0.000264	0.00252	CbGeAlD
Caffeine—ADORA1—lymph node—acquired immunodeficiency syndrome	0.000263	0.00252	CbGeAlD
Caffeine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.00229	CcSEcCtD
Caffeine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.00227	CcSEcCtD
Caffeine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00227	CcSEcCtD
Caffeine—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000258	0.00247	CbGeAlD
Caffeine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00224	CcSEcCtD
Caffeine—PDE4B—central nervous system—acquired immunodeficiency syndrome	0.000254	0.00243	CbGeAlD
Caffeine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.0022	CcSEcCtD
Caffeine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.00218	CcSEcCtD
Caffeine—CYP1B1—lung—acquired immunodeficiency syndrome	0.000244	0.00233	CbGeAlD
Caffeine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00212	CcSEcCtD
Caffeine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.00212	CcSEcCtD
Caffeine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00208	CcSEcCtD
Caffeine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000235	0.00206	CcSEcCtD
Caffeine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000235	0.00206	CcSEcCtD
Caffeine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00203	CcSEcCtD
Caffeine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00202	CcSEcCtD
Caffeine—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000226	0.00216	CbGeAlD
Caffeine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000219	0.00192	CcSEcCtD
Caffeine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000219	0.00192	CcSEcCtD
Caffeine—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000218	0.00208	CbGeAlD
Caffeine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00188	CcSEcCtD
Caffeine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000213	0.00204	CbGeAlD
Caffeine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00021	0.002	CbGeAlD
Caffeine—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000207	0.00198	CbGeAlD
Caffeine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.00181	CcSEcCtD
Caffeine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.00181	CcSEcCtD
Caffeine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00181	CcSEcCtD
Caffeine—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000202	0.00193	CbGeAlD
Caffeine—PDE4B—brain—acquired immunodeficiency syndrome	0.000202	0.00193	CbGeAlD
Caffeine—CYP1A2—blood—acquired immunodeficiency syndrome	0.0002	0.00191	CbGeAlD
Caffeine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000199	0.0019	CbGeAlD
Caffeine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.00174	CcSEcCtD
Caffeine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000198	0.00189	CbGeAlD
Caffeine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.00173	CcSEcCtD
Caffeine—CYP1A1—blood—acquired immunodeficiency syndrome	0.000197	0.00188	CbGeAlD
Caffeine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.00172	CcSEcCtD
Caffeine—PDE4B—lymph node—acquired immunodeficiency syndrome	0.000195	0.00186	CbGeAlD
Caffeine—CYP3A5—blood—acquired immunodeficiency syndrome	0.000193	0.00184	CbGeAlD
Caffeine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000191	0.00182	CbGeAlD
Caffeine—CYP2C9—blood—acquired immunodeficiency syndrome	0.00019	0.00181	CbGeAlD
Caffeine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000189	0.0018	CbGeAlD
Caffeine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.00161	CcSEcCtD
Caffeine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.0016	CcSEcCtD
Caffeine—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000183	0.00174	CbGeAlD
Caffeine—CYP2E1—blood—acquired immunodeficiency syndrome	0.00018	0.00172	CbGeAlD
Caffeine—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000178	0.00171	CbGeAlD
Caffeine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.00155	CcSEcCtD
Caffeine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.00154	CcSEcCtD
Caffeine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000175	0.00167	CbGeAlD
Caffeine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000173	0.00165	CbGeAlD
Caffeine—CYP1B1—brain—acquired immunodeficiency syndrome	0.000173	0.00165	CbGeAlD
Caffeine—CYP1A1—lung—acquired immunodeficiency syndrome	0.000173	0.00165	CbGeAlD
Caffeine—CYP3A5—lung—acquired immunodeficiency syndrome	0.000169	0.00161	CbGeAlD
Caffeine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.00147	CcSEcCtD
Caffeine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.00147	CcSEcCtD
Caffeine—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000167	0.0016	CbGeAlD
Caffeine—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.00016	0.00153	CbGeAlD
Caffeine—CYP2E1—lung—acquired immunodeficiency syndrome	0.000157	0.0015	CbGeAlD
Caffeine—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000154	0.00147	CbGeAlD
Caffeine—ABCB1—retina—acquired immunodeficiency syndrome	0.000153	0.00146	CbGeAlD
Caffeine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000152	0.00145	CbGeAlD
Caffeine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000149	0.00143	CbGeAlD
Caffeine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000146	0.00139	CbGeAlD
Caffeine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000145	0.00138	CbGeAlD
Caffeine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000142	0.00136	CbGeAlD
Caffeine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.00014	0.00134	CbGeAlD
Caffeine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000132	0.00126	CbGeAlD
Caffeine—CYP1A1—brain—acquired immunodeficiency syndrome	0.000122	0.00117	CbGeAlD
Caffeine—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000118	0.00113	CbGeAlD
Caffeine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000117	0.00112	CbGeAlD
Caffeine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000115	0.0011	CbGeAlD
Caffeine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000113	0.00108	CbGeAlD
Caffeine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000111	0.00106	CbGeAlD
Caffeine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000111	0.00106	CbGeAlD
Caffeine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000109	0.00104	CbGeAlD
Caffeine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000107	0.00103	CbGeAlD
Caffeine—ABCB1—blood—acquired immunodeficiency syndrome	0.000102	0.000977	CbGeAlD
Caffeine—ABCB1—bone marrow—acquired immunodeficiency syndrome	9.9e-05	0.000946	CbGeAlD
Caffeine—ABCB1—spinal cord—acquired immunodeficiency syndrome	9.86e-05	0.000942	CbGeAlD
Caffeine—ABCB1—vagina—acquired immunodeficiency syndrome	9.48e-05	0.000906	CbGeAlD
Caffeine—ABCB1—lung—acquired immunodeficiency syndrome	8.97e-05	0.000857	CbGeAlD
Caffeine—CYP2D6—brain—acquired immunodeficiency syndrome	8.82e-05	0.000843	CbGeAlD
Caffeine—ABCB1—nervous system—acquired immunodeficiency syndrome	8.3e-05	0.000793	CbGeAlD
Caffeine—ABCB1—central nervous system—acquired immunodeficiency syndrome	8e-05	0.000764	CbGeAlD
Caffeine—ABCB1—brain—acquired immunodeficiency syndrome	6.35e-05	0.000606	CbGeAlD
Caffeine—ABCB1—lymph node—acquired immunodeficiency syndrome	6.13e-05	0.000586	CbGeAlD
Caffeine—PIK3CA—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	4.2e-05	0.000475	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.19e-05	0.000473	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.19e-05	0.000473	CbGpPWpGaD
Caffeine—PIK3CA—DAP12 signaling—IL6—acquired immunodeficiency syndrome	4.18e-05	0.000473	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.18e-05	0.000472	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CD8A—acquired immunodeficiency syndrome	4.17e-05	0.000472	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CSF2—acquired immunodeficiency syndrome	4.17e-05	0.000472	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	4.12e-05	0.000466	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.12e-05	0.000465	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—CD4—acquired immunodeficiency syndrome	4.12e-05	0.000465	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.11e-05	0.000464	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CCR2—acquired immunodeficiency syndrome	4.07e-05	0.00046	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.06e-05	0.000459	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.05e-05	0.000458	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.04e-05	0.000457	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HLA-B—acquired immunodeficiency syndrome	4.01e-05	0.000454	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.01e-05	0.000453	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4e-05	0.000453	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.98e-05	0.00045	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.97e-05	0.000449	CbGpPWpGaD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	3.97e-05	0.000449	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	3.95e-05	0.000447	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.94e-05	0.000446	CbGpPWpGaD
Caffeine—PIK3CA—DAP12 interactions—IL6—acquired immunodeficiency syndrome	3.93e-05	0.000445	CbGpPWpGaD
Caffeine—PIK3CA—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	3.93e-05	0.000445	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	3.93e-05	0.000445	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3.9e-05	0.000441	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	3.9e-05	0.000441	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.89e-05	0.000439	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.89e-05	0.000439	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IFNG—acquired immunodeficiency syndrome	3.88e-05	0.000438	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	3.87e-05	0.000437	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	3.85e-05	0.000435	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.83e-05	0.000433	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.81e-05	0.00043	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.81e-05	0.00043	CbGpPWpGaD
Caffeine—ADORA1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.8e-05	0.000429	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.75e-05	0.000424	CbGpPWpGaD
Caffeine—PRKDC—Immune System—CD4—acquired immunodeficiency syndrome	3.74e-05	0.000423	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	3.71e-05	0.000419	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.71e-05	0.000419	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.69e-05	0.000418	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.69e-05	0.000417	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD40LG—acquired immunodeficiency syndrome	3.68e-05	0.000416	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.68e-05	0.000415	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—IL2—acquired immunodeficiency syndrome	3.67e-05	0.000414	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IFNA1—acquired immunodeficiency syndrome	3.66e-05	0.000414	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.66e-05	0.000414	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.66e-05	0.000413	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.65e-05	0.000413	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.64e-05	0.000412	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CSF2—acquired immunodeficiency syndrome	3.64e-05	0.000411	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD8A—acquired immunodeficiency syndrome	3.64e-05	0.000411	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.62e-05	0.00041	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.61e-05	0.000408	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.6e-05	0.000407	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.6e-05	0.000407	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.59e-05	0.000405	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—ALB—acquired immunodeficiency syndrome	3.56e-05	0.000403	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD79A—acquired immunodeficiency syndrome	3.56e-05	0.000402	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CXCR4—acquired immunodeficiency syndrome	3.53e-05	0.000399	CbGpPWpGaD
Caffeine—PIK3CD—Disease—CCR5—acquired immunodeficiency syndrome	3.52e-05	0.000398	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.51e-05	0.000397	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.51e-05	0.000396	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HLA-B—acquired immunodeficiency syndrome	3.5e-05	0.000396	CbGpPWpGaD
Caffeine—PIK3CA—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	3.48e-05	0.000394	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—IL6—acquired immunodeficiency syndrome	3.48e-05	0.000393	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	3.46e-05	0.000391	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.46e-05	0.000391	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.46e-05	0.000391	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.46e-05	0.000391	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL2—acquired immunodeficiency syndrome	3.45e-05	0.000389	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	3.44e-05	0.000389	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.41e-05	0.000385	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3.4e-05	0.000384	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.38e-05	0.000382	CbGpPWpGaD
Caffeine—PIK3CA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.37e-05	0.000381	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.36e-05	0.00038	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.35e-05	0.000379	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.34e-05	0.000377	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.34e-05	0.000377	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.31e-05	0.000375	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.31e-05	0.000374	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	3.28e-05	0.000371	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	3.28e-05	0.000371	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.24e-05	0.000367	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.19e-05	0.00036	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.16e-05	0.000357	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	3.16e-05	0.000357	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	3.15e-05	0.000356	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.14e-05	0.000355	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.14e-05	0.000355	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.14e-05	0.000355	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.11e-05	0.000352	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.11e-05	0.000352	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.11e-05	0.000352	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.07e-05	0.000347	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CCR5—acquired immunodeficiency syndrome	3.07e-05	0.000347	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.07e-05	0.000347	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.03e-05	0.000343	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.98e-05	0.000336	CbGpPWpGaD
Caffeine—ADORA2A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.93e-05	0.000332	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.91e-05	0.000329	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD40LG—acquired immunodeficiency syndrome	2.9e-05	0.000328	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.9e-05	0.000327	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—IL2—acquired immunodeficiency syndrome	2.89e-05	0.000327	CbGpPWpGaD
Caffeine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.88e-05	0.000325	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.87e-05	0.000324	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD8A—acquired immunodeficiency syndrome	2.87e-05	0.000324	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CSF2—acquired immunodeficiency syndrome	2.87e-05	0.000324	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.85e-05	0.000322	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.83e-05	0.00032	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.81e-05	0.000318	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.78e-05	0.000314	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-B—acquired immunodeficiency syndrome	2.76e-05	0.000312	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.74e-05	0.00031	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	2.73e-05	0.000308	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	2.73e-05	0.000308	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	2.71e-05	0.000307	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.7e-05	0.000305	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.68e-05	0.000303	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.68e-05	0.000303	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	2.68e-05	0.000303	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.67e-05	0.000302	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.66e-05	0.0003	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.64e-05	0.000299	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.64e-05	0.000299	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.63e-05	0.000297	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.63e-05	0.000297	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.61e-05	0.000295	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.61e-05	0.000295	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.61e-05	0.000295	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.59e-05	0.000293	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.53e-05	0.000286	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IFNG—acquired immunodeficiency syndrome	2.48e-05	0.000281	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.47e-05	0.00028	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.47e-05	0.00028	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.47e-05	0.000279	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CCR5—acquired immunodeficiency syndrome	2.42e-05	0.000274	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.41e-05	0.000273	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.4e-05	0.000271	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CD4—acquired immunodeficiency syndrome	2.4e-05	0.000271	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.39e-05	0.00027	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.38e-05	0.000269	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.37e-05	0.000268	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.37e-05	0.000267	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.35e-05	0.000266	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.33e-05	0.000263	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	2.32e-05	0.000262	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.32e-05	0.000262	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.3e-05	0.000259	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	2.24e-05	0.000253	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.23e-05	0.000252	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	2.22e-05	0.000251	CbGpPWpGaD
Caffeine—PIK3CD—Disease—CD4—acquired immunodeficiency syndrome	2.21e-05	0.00025	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.21e-05	0.00025	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL2—acquired immunodeficiency syndrome	2.21e-05	0.000249	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.17e-05	0.000245	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IFNG—acquired immunodeficiency syndrome	2.16e-05	0.000245	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.15e-05	0.000243	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.13e-05	0.000241	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.1e-05	0.000238	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—ALB—acquired immunodeficiency syndrome	2.1e-05	0.000238	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD4—acquired immunodeficiency syndrome	2.09e-05	0.000236	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.08e-05	0.000236	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.04e-05	0.000231	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.04e-05	0.000231	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL6—acquired immunodeficiency syndrome	2.03e-05	0.000229	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.02e-05	0.000228	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.01e-05	0.000227	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.99e-05	0.000225	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.98e-05	0.000224	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.96e-05	0.000221	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.95e-05	0.000221	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.94e-05	0.000219	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CD4—acquired immunodeficiency syndrome	1.93e-05	0.000218	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.93e-05	0.000218	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL2—acquired immunodeficiency syndrome	1.92e-05	0.000217	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.9e-05	0.000215	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.9e-05	0.000215	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.89e-05	0.000214	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.89e-05	0.000213	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.88e-05	0.000213	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.85e-05	0.000209	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—ALB—acquired immunodeficiency syndrome	1.83e-05	0.000207	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.83e-05	0.000206	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.81e-05	0.000205	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.79e-05	0.000202	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.77e-05	0.0002	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.75e-05	0.000198	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IFNG—acquired immunodeficiency syndrome	1.7e-05	0.000193	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.7e-05	0.000192	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.66e-05	0.000187	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD4—acquired immunodeficiency syndrome	1.65e-05	0.000186	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.61e-05	0.000182	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.55e-05	0.000176	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.53e-05	0.000173	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.53e-05	0.000173	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CD4—acquired immunodeficiency syndrome	1.52e-05	0.000172	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000171	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.51e-05	0.00017	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.46e-05	0.000166	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—ALB—acquired immunodeficiency syndrome	1.44e-05	0.000163	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000161	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.42e-05	0.00016	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.4e-05	0.000158	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000155	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.32e-05	0.000149	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL6—acquired immunodeficiency syndrome	1.3e-05	0.000147	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.25e-05	0.000141	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.24e-05	0.00014	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.24e-05	0.00014	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000139	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.23e-05	0.000139	CbGpPWpGaD
Caffeine—PIK3CD—Disease—IL6—acquired immunodeficiency syndrome	1.2e-05	0.000135	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.17e-05	0.000132	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL6—acquired immunodeficiency syndrome	1.13e-05	0.000128	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.07e-05	0.000121	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000118	CbGpPWpGaD
Caffeine—PIK3CB—Disease—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000118	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000118	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000117	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.03e-05	0.000116	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.79e-06	0.000111	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.75e-06	0.00011	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL6—acquired immunodeficiency syndrome	8.9e-06	0.000101	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.85e-06	0.0001	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.7e-06	9.83e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	8.43e-06	9.53e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.38e-06	9.47e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—IL6—acquired immunodeficiency syndrome	8.22e-06	9.29e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.08e-06	9.14e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.04e-06	9.09e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	7.6e-06	8.59e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.43e-06	8.4e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.31e-06	8.26e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.24e-06	8.18e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.15e-06	6.96e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.08e-06	6.87e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.76e-06	6.51e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	5.51e-06	6.22e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	5.49e-06	6.21e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.19e-06	5.87e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	4.76e-06	5.38e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.75e-06	5.37e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.15e-06	4.69e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.91e-06	4.42e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	3.87e-06	4.38e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.31e-06	3.74e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.55e-06	2.89e-05	CbGpPWpGaD
